Pharmacodynamics of 2 dosages of orally administered esomeprazole in client-owned, healthy dogs: A prospective, crossover study
Open Access
- 1 November 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 38 (6) , 3235-3241
Abstract
Background: Esomeprazole use is increasing in dogs, but the gastrointestinal adverse events associated with q12h dosing necessitate pharmacodynamic evaluation of a reduced dose and frequency of administration. Objectives: To compare the efficacy of 2 doses of (q24h) esomeprazole in raising intragastric pH in dogs. Animals: Nine healthy, client-owned dogs, >20 kg. Methods: Prospective, randomized, double blinded, crossover study. Esomeprazole (0.5 or 1 mg/kg q24h) was orally administered for up to 5 days per treatment arm, and the mean percentage time intragastric pH was ≥3 (MPT3) and ≥4 (MPT4) for 24 hours periods were compared to pretreatment pH using a continuous pH monitoring system. Dogs failing to reach pH goals (MPT3 ≥75%, MPT4 ≥66%) with once daily dosing received esomeprazole 1 mg/kg PO q12h to determine if a higher dose would improve acid suppression. Results: No significant difference in the MPT3 or MPT4 was identified between treatments for any time point (P > .05). Both doses increased the MPT pH ≥3 and 4 median [range] (0.5 mg/kg, 1 mg/kg) on days 1 (MPT3: 76.8% [44-100], 69.2% [28.2-100]; MPT4: 65.6% [16.7-99.3], 54.9% [14.9-93.3]; P = .0009) and 2 (MPT3:77.2% [27.4-100], 75.4% [49.4-89.5]; MPT4: 66.3% [15.5-100], 59.7% [33.8-81.2]; P = .0005) of PPI treatment compared to pretreatment (MPT3: 58.3% [0.02-93.9], 52.6% [6.1-94.7]; MPT4: 25.2% [0-86.8], 32.4% [1.8-89.3]). Six dogs (66%, [0.36, 0.97]) reached pH goals established in humans with q24h dosing. Conclusions and Clinical Importance: Both q24h PO esomeprazole doses were effective in raising intragastric pH, despite high intersubject variability, but 33% of dogs required q12h dosing to reach pH goals.Keywords
This publication has 18 references indexed in Scilit:
- Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogsJournal of Veterinary Internal Medicine, 2020
- Pharmacokinetics and pharmacodynamics of intravenous esomeprazole at 2 different dosages in dogsJournal of Veterinary Internal Medicine, 2018
- ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and catsJournal of Veterinary Internal Medicine, 2018
- Pharmacokinetics and Acid Suppressant Efficacy of Esomeprazole after Intravenous, Oral, and Subcutaneous Administration to Healthy Beagle DogsJournal of Veterinary Internal Medicine, 2017
- Efficacy of Intravenous Administration of Combined Acid Suppressants in Healthy DogsJournal of Veterinary Internal Medicine, 2015
- Efficacy of Oral Famotidine and 2 Omeprazole Formulations for the Control of Intragastric pH in DogsJournal of Veterinary Internal Medicine, 2010
- Review article: gastric acidity − comparison of esomeprazole with other proton pump inhibitorsAlimentary Pharmacology & Therapeutics, 2003
- Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trialAmerican Journal of Gastroenterology, 2001
- Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trialAlimentary Pharmacology & Therapeutics, 2000
- Is there an optimal degree of acid suppression for healing of duodenal ulcers?Gastroenterology, 1990